Condition: Multifocal Motor Neuropathy · Sponsor: argenx
This prospective longitudinal study will follow participants with Multifocal Motor Neuropathy over time and collect data on their clinical outcomes, quality of life, and use of health care resources. Participants will follow their regular visit schedule with their treating physician, except for an optional second visit occurring 7 to 14 days after the start of the study to collect biomarker data. No IMP will be administered.
This description comes directly from the study's public registry record.
No contact information is available for this study as per the public registry record.
Always discuss trial participation with your own doctor first.
| Neuromuscular Clinical and Research Center | Phoenix, Arizona, United States | — |
| HonorHealth Neurology - Bob Bove Neuroscience Institute | Scottsdale, Arizona, United States | — |
| UCI Health - ALS and Neuromuscular Center | Orange, California, United States | — |
| Stanford Medicine Health Care - Stanford Neuroscience Health Center | Palo Alto, California, United States | — |
| The Neurology Group | Pomona, California, United States | — |
| Eisenhower Health - Rancho Mirage Medical Center | Rancho Mirage, California, United States | — |
| UC Davis Health - Lawrence J. Ellison Ambulatory Care Center | Sacramento, California, United States | — |
| UCSF Health - UCSF Medical Center | San Francisco, California, United States | — |
| University of Colorado - Anschutz Medical Campus | Aurora, Colorado, United States | — |
| YaleNewHavenHealth - Yale New Haven Hospital | New Haven, Connecticut, United States | — |
| MedStar Georgetown University Hospital | Washington D.C., District of Columbia, United States | — |
| Medsol Clinical Research Center Inc | Port Charlotte, Florida, United States | — |
+ 102 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.